Association of multiple sclerosis with stroke: A comprehensive review
Open Access
- 23 January 2024
- journal article
- research article
- Published by Wiley in Health Science Reports
- Vol. 7 (1) , e1837
Abstract
Background: Multiple sclerosis (MS) is a chronic immune‐mediated disorder characterized by the degradation of the myelin sheath in the central nervous system. Research indicates that individuals with MS exhibit a higher susceptibility to stroke compared to the general population. This association is rooted in shared underlying mechanisms, specifically involving neuroinflammatory processes.Methodology: We performed an extensive search on PubMed, MEDLINE, Embase, Scopus, and Google Scholar using specific terms. The search terms included variations of “multiple sclerosis,” “stroke,” “cerebrovascular disease,” “vascular risk factors,” “disease‐modifying therapies,” and “neuroinflammation.” The search was limited to articles published from January 1, 2000, up to 31 May, 2023.Results and Discussion: Stroke, a global health burden characterized by significant mortality and adult disability, underscores the critical importance of understanding the link between MS and stroke. Despite a growing body of research establishing an elevated risk of stroke in MS patients, notable information gaps persist. Limited prospective multicenter studies on stroke incidence in MS patients contribute to an incomplete understanding of the precise relationship between these two conditions.Conclusion: In conclusion, this review underscores the critical need for a thorough understanding of the complex relationship between MS and stroke. The identified risk factors and the influence of MS DMTs on stroke risk necessitate further investigation to inform evidence‐based preventive and therapeutic strategies. Bridging the existing information gaps through prospective multicenter studies is imperative for a comprehensive understanding of this association. The development of targeted diagnostic and therapeutic approaches for acute stroke risk in MS patients is paramount to mitigate the impact of these debilitating conditions. Ultimately, this review serves as a foundation for future efforts to enhance preventative measures and therapeutic interventions, thereby improving the overall quality of life for individuals with MS susceptible to strokes.Keywords
This publication has 74 references indexed in Scilit:
- Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1Proceedings of the National Academy of Sciences, 2013
- High risk of cardiovascular diseases after diagnosis of multiple sclerosisMultiple Sclerosis Journal, 2013
- Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage studyBMC Medicine, 2011
- Vascular comorbidity is associated with more rapid disability progression in multiple sclerosisNeurology, 2010
- A Comparison of 3T and 7T in the Detection of Small Parenchymal Veins Within MS LesionsInvestigative Radiology, 2009
- Atherosclerotic Burden Findings in Young Cryptogenic Stroke Patients With and Without a Patent Foramen OvaleStroke, 2009
- StrokeThe Lancet, 2008
- Variation of serum uric acid levels in multiple sclerosis during relapses and immunomodulatory treatmentEuropean Journal of Neurology, 2008
- Prospects for the prevention of strokeJournal Of Hypertension, 2006
- New Evidence for Stroke PreventionJAMA, 2002